Impact of essential hypertension and primary aldosteronism on plasma brain natriuretic peptide concentration

Blood Pressure

Volumn 15, Issue 5, 2006, Pages 302-307

  Jakubik, P ^a   Janota, T ^a   Widimsky, Jr ^a   Zelinka, T ^a   Strauch, B ^a   Petrak, O ^a   Benakova, H ^a   Bezdickova, D ^a   Wichterle, D ^b   Zima, T ^a   Hradec, J ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Brain natriuretic peptide; Essential hypertension; Primary aldosteronism

Indexed keywords

ALDOSTERONE; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; PRAZOSIN;

ADRENAL HYPERPLASIA; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ENDOCRINE TUMOR; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE SEPTUM; HUMAN; MALE; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; SODIUM RESTRICTION;

ADULT; AGED; BLOOD PRESSURE; CASE-CONTROL STUDIES; DIASTOLE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN;

EID: 33847229451     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08037050601037760     Document Type: Article

References (33)

1. Maisel, A. S., Koon, J., Krishnaswamy, P., Kazenegra, R., Clopton, P. and Gardetto, N. (2001) Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J, 141, pp. 367-374.
2. Clerico, A., Iervasi, G., Chicca, M. G. Del, Emdin, M., Maffei, S. and Nannipieri, M. (1998) Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific imunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest, 21, pp. 170-179.
3. Morrison, L. K., Harrison, A., Krishnaswamy, P., Kazanegra, R., Clopton, P. and Maisel, A. (2002) Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Col Cardiol, 39, pp. 202-209.
4. Davidson, N. C., Naas, A. A., Hanson, J. K., Kennedy, N. S., Coutie, W. J. and Struthers, A. D. (1996) Comparison of atrial natriuretic peptide, B-type natriuretic peptide and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. Am J Cardiol, 77, pp. 828-831.
5. Stein, B. and Levin, R. (1998) Natriuretic peptides: Physiological, therapeutical potential, and risk stratification in ischaemic heart disease. Am Heart J, 135, pp. 914-923.
6. Dahlstrom, U. (2004) Can natriuretic peptides be used for the diagnosis of diastolic heart failure?. Eur J Heart Fail, 6, pp. 281-287.
7. Hunt, S. A., American College of Cardiology and American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) (2005) ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol, 46, p. e1.
8. Swedberg, K., Cleland, J., Dargie, H., Drexler, H., Follath, F. and Komajda, M. (2005) Guidelines for the diagnosis and treatment of chronic heart failure: Executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 26, pp. 1115-1140.
9. Kohno, M., Yasunari, K., Yokokawa, K., Horio, T., Kano, H. and Minami, M. (1996) Plasma brain natriuretic peptide during ergometric exercise in hypertensive patients with left ventricular hypertrophy. Metabolism, 45, pp. 1326-1329.
10. Buckley, M. G., Markandu, N. D., Miller, M. A., Sagnella, G. A. and MacGregor, G. A. (1993) Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. J Hum Hypertens, 7, pp. 245-250.
11. Olsen, M. H., Wachtell, K., Tuxen, C., Fossum, E., Bang, L. E. and Hall, C. (2004) N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: A LIFE study. J Hypertens, 22, pp. 1597-1604.
12. Cheung, B. M. and Brown, M. J. (1994) Plasma brain natriuretic peptide and C-type natriuretic peptide in essential hypertension. J Hypertens, 12, pp. 449-454.
13. Tanaka, M., Ishizaka, Y., Ishiyama, Y., Kato, J., Kida, O. and Kitamura, K. (1995) Exercise-induced secretion of BNP in essential hypertension and normal subjects. Hypertens Res, 18, pp. 159-166.
14. Kohno, M., Horio, T., Yokokawa, K., Murakawa, K., Yasunari, K. and Akioka, K. (1992) Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med, 92, pp. 29-34.
15. Hildebrandt, P., Bosen, M., Michael, O., Wachtell, K. and Groenning, B. (2004) N-terminal pro brain natriuretic peptide in arterial hypertension - A marker for left ventricular dimensions and prognosis. Eur J Heart Fail, 6, pp. 313-317.
16. Almeida, P., Azevedo, A., Rodrigues, R., Dias, P., Frioes, F. and Vazquez, B. (2003) B-type natriuretic peptide and left ventricular hypertrophy in hypertensive patients. Rev Port Cardiol, 22, pp. 327-336.
17. Nishikimi, T., Yoshihara, F., Morimoto, A., Ishikawa, K., Ishimitsu, T. and Saito, Y. (1996) Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension, 28, pp. 22-30.
18. Talwar, S., Siebenhofer, A., Williams, B. and Ng, L. (2000) Influence of hypertension, left ventricular hypertrophy and left ventricular systolic dysfunction on plasma N-terminal proBNP. Heart, 83, pp. 278-282.
19. Wei, T., Zeng, C., Chen, L., Chen, Q., Zhao, R. and Lu, G. (2005) Bedside tests of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients. Eur J Heart Fail, 7, pp. 75-79.
20. Lee, Y. J., Lin, S. R., Shin, S. J., Lai, Y. H., Lin, Y. T. and Tsai, J. H. (1994) Brain natriuretic peptide is synthesized in the human adrenal medulla and its messenger ribonucleic acid expression along with that of atrial natriuretic peptide are enhanced in patients with primary aldosteronism. J Clin Endocrin Metab, 79, pp. 1476-1482.
21. Kato, J., Etoh, T., Kitamura, K. and Eto, T. (2005) Atrial and brain natriuretic peptides as markers of cardiac load and volume retention in primary hyperaldosteronism. Am J Hypertens, 18, pp. 354-357.
22. Strauch, B., Zelinka, T., Hampf, M., Bernhardt, R. and Widimsky Jr., J. (2003) Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region. J Hum Hypertens, 17, pp. 349-352.
23. (1964) The Declaration of Helsinki. Br Med J, p. 177.
24. Fontes, R. G., Kater, C. E., Biglieri, E. G. and Irony, I. (1991) Reassessment of the predictive value of the postural stimulation test in primary aldosteronism. Am J Hypertens, 4, pp. 786-791.
25. Kem, D. C., Weinberger, M. H., Mayes, D. M. and Nugent, C. A. (1971) Saline suppression of plasma aldosterone in hypertension. Arch Intern Med, 128, pp. 380-386.
26. Kaplan, N. M. (2002) Clinical hypertension. 8th ed: Primary aldosteronism, pp. 459-465. Lippincott Williams and Wilkins, Philadelphia, PA
27. Ganguly, A. (1998) Primary aldosteronism. N Engl J Med, 399, pp. 1828-1834.
28. Sahn, D. J., DeMaria, A., Kisslo, J. and Weyman, A. (1978) Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation, 58, pp. 1072-1083.
29. Devereux, R. B. (1987) Detection of left ventricular hypertrophy by M-mode echocardiography: Anatomic validation, standardization, and comparison to other methods. Hypertension, 9, pp. 19-26.
30. Linhart, A., Abergel, E., Hrudova, J. and Horky, K. (1999) The importance and methods of echocardiographic evaluation of left ventricle mass in patients with arterial hypertension. Cor Vasa., 41, pp. 393-402.
31. Teichholz, L. E., Kreulen, T., Herman, M. V. and Gorlin, R. (1976) Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy. J Am Cardiol, 37, pp. 7-11.
32. Weyman (1994) Principles and practice of echocardiography. 2nd ed, pp. 728-729. Lea & Febiger, Malvern, PA
33. Jakubik, P., Janota, T., Wichterle, D., Widimsky Jr., J., Benakova, H. and Zelinka, T. (2006) Can severe essential hypertension raise BNP levels resulting in a misdiagnosis of heart failure?. Cor Vasa, 48, pp. 48-54.